{"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"groups":[{"description":"Nivolumab 240 mg/body solution intravenously every 2 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends","id":"BG000","title":"Nivolumab Arm"},{"description":"Docetaxel: Intravenously administered at a dose of 75 mg/m2 every 3 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends\n\nOR\n\nPaclitaxel: Intravenously administered at a dose of 100 mg/m2 weekly for 6 weeks followed by 2-week drug holiday until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends","id":"BG001","title":"Active Comparator Arm （Docetaxel/Paclitaxel）"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"112"},{"groupId":"BG001","value":"85"},{"groupId":"BG002","value":"197"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"98"},{"groupId":"BG001","value":"124"},{"groupId":"BG002","value":"222"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"57","upperLimit":"69","value":"64"},{"groupId":"BG001","lowerLimit":"57","upperLimit":"72","value":"67"},{"groupId":"BG002","lowerLimit":"57","upperLimit":"71","value":"65"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"55"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"179"},{"groupId":"BG001","value":"185"},{"groupId":"BG002","value":"364"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"201"},{"groupId":"BG001","value":"200"},{"groupId":"BG002","value":"401"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"18"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"201"},{"groupId":"BG001","value":"200"},{"groupId":"BG002","value":"401"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"18"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"White"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"107"},{"groupId":"BG002","value":"208"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"109"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"211"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"1"}],"description":"performance status 0；Fully active, able to continue all pre-disease activities without restriction performance status 1；Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG performance status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"21"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"120"},{"groupId":"BG002","value":"227"}],"units":"Participants"}],"title":"II - III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"94"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"194"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"120"},{"groupId":"BG002","value":"227"}],"units":"Participants"}],"title":"IV"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"120"},{"groupId":"BG002","value":"227"}],"units":"Participants"}],"title":"unknown"}],"description":"In this study, the TNM Classification of Malignant Tumours, Seventh Edition, published by the Union for International Cancer Control (UICC) (hereinafter referred to as \"the TNM classification\") will be used to determine disease stage. please refer to the protocol information. Higher numbers mean the cancer is more advanced.","paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Summarized for subjects with non-recurrent esophageal cancer.","title":"Disease stage : TNM classification","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"111"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"205"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Surgery"},{"categories":[{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"142"},{"groupId":"BG002","value":"295"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Radiothrapy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"208"},{"groupId":"BG002","value":"418"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Systemic anticancer therapy"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Previous therapies","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"180"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"<=1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"121"},{"groupId":"BG001","value":"118"},{"groupId":"BG002","value":"239"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":">=2"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of organs of metastases","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"159"},{"groupId":"BG001","value":"163"},{"groupId":"BG002","value":"322"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Lymph node"},{"categories":[{"measurements":[{"groupId":"BG000","value":"57"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"111"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Liver"},{"categories":[{"measurements":[{"groupId":"BG000","value":"98"},{"groupId":"BG001","value":"92"},{"groupId":"BG002","value":"190"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Lung"},{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"48"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Bone"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Site of metastases","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"109"},{"groupId":"BG001","value":"107"},{"groupId":"BG002","value":"216"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"<1%"},{"categories":[{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"203"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":">=1%"},{"categories":[{"measurements":[{"groupId":"BG000","value":"136"},{"groupId":"BG001","value":"137"},{"groupId":"BG002","value":"273"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"<5%"},{"categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"146"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":">=5%"},{"categories":[{"measurements":[{"groupId":"BG000","value":"146"},{"groupId":"BG001","value":"152"},{"groupId":"BG002","value":"298"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"<10%"},{"categories":[{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"57"},{"groupId":"BG002","value":"121"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":">=10%"}],"description":"In this study, the subject will test positive for PD-L1 when cancerous cells with stained cell membranes account for ≧1% of at least 100 evaluable cancerous cells and will test negative for PD-L1 when such cells account for \\<1%, the same applies to 5% and 10%.","paramType":"COUNT_OF_PARTICIPANTS","title":"PD-L1 expression","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"62"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Never"},{"categories":[{"measurements":[{"groupId":"BG000","value":"159"},{"groupId":"BG001","value":"147"},{"groupId":"BG002","value":"306"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Former"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"51"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"419"}],"units":"Participants"}],"title":"Current"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"History of smoking","unitOfMeasure":"Participants"}]}